Extract I read with great interest the recent review discussing the challenges of defining and achieving remission in asthma 1. While the authors aptly highlight the limitations of current remission criteria, including symptom variability, biomarker fluctuations and comorbidity impacts, I propose that this debate presents an opportunity to explore patient-centred, multidimensional assessment approaches, with tools like the CompOsite iNdex For Response in asthMa (CONFIRM) offering one potential framework 2.
Vanesa Bellou (Thu,) studied this question.